Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 17/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 16/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.44 |
| ▸ | TRAP1 | Q12931 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6153979 | 0.95 | HSP90AB1 (0.50) | HSP90AB1HSP90AA1CYP2C19HSP90B1TRAP1 | |
| SCHEMBL7813344 | 0.83 | CYP2C19 (0.46) | HSP90AB1HSP90AA1CYP2C19HDAC1 | |
| SCHEMBL14227939 | 0.80 | HSP90AB1 (0.43) | HSP90AB1HSP90AA1CYP2C19HSP90B1TRAP1 | |
| SCHEMBL10521672 | 0.78 | HSP90AB1 (0.39) | HSP90AB1HSP90AA1HSP90B1TRAP1HDAC6 | |
| SCHEMBL28451668 | 0.78 | HSP90AB1 (0.49) | HSP90AB1HSP90AA1CYP2C19HSP90B1TRAP1 | |
| SCHEMBL13645718 | 0.78 | HSP90AB1 (0.51) | HSP90AB1HSP90AA1CYP2C19HSP90B1TRAP1 | |
| SCHEMBL8649570 | 0.77 | HSP90AB1 (0.55) | HSP90AB1HSP90AA1HSP90B1TRAP1HDAC6 | |
| SCHEMBL28439303 | 0.77 | ADORA2A (0.37) | HSP90AB1HSP90AA1 | |
| SCHEMBL10917478 | 0.77 | HSP90AB1 (0.50) | HSP90AB1HSP90AA1HSP90B1TRAP1HDAC6 | |
| SCHEMBL9116660 | 0.77 | HSP90AB1 (0.46) | HSP90AB1HSP90AA1HSP90B1TRAP1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6806375-B2 | SUCH AS FAMCICLOVIR AND PENCICLOVIR; REACTING A 2-AMINOPURINE WITH A 1,1-BIS(OXYMETHYL)-1-VINYLMETHYL CARBONATE, ESTER OR PHOSPHATE IN THE PRESENCE OF A PALLADIUM(0) CATALYST | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2004-10-19 | — | — | US | disclosed |
| US-6555685-B1 | Preparing purine derivatives, such as famiciclovir and penciclovir, by reacting, in the presence of a palladium catalyst and ligand; by-product inhibition; efficiency | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2003-04-29 | — | — | US | disclosed |